incredible-marketing Arrow

VOLUMA™ XC in San Francisco

As people age, the cheek area loses volume, making the cheeks flatten out and the skin droop and sag. JUVÉDERM VOLUMA™ XC was recently approved by the FDA and the first and only filler approved to temporarily correct age-related volume loss in the cheek area in adults age 21 and over. It instantly provides smooth, natural-looking results that last up to two years with optimal correction.

With the FDA approval of JUVÉDERM VOLUMA™ XC, physicians and patients in the U.S. now have a new treatment option that can help create a natural-looking, more youthful appearance in the cheek area.

I would welcome the opportunity to discuss why and how the face loses volume as people age. I can also speak about how JUVÉDERM VOLUMA™ XC is an effective non-surgical treatment option for age-related volume loss in the cheek area.

APPROVED USE

JUVÉDERM VOLUMA™ XC injectable gel is for deep injection in the cheek area to correct age-related volume loss in adults over the age of 21.

IMPORTANT SAFETY INFORMATION

Are there any reasons why I should not receive JUVÉDERM VOLUMA™ XC?

Do not use the product if you have severe allergies with a history of severe allergic reactions (anaphylaxis), or if you are allergic to lidocaine or the proteins (gram-positive bacterial proteins) used to make the hyaluronic acid (HA) in JUVÉDERM VOLUMA™ XC.

What precautions should my doctor advise me about?

  • The safety of JUVÉDERM VOLUMA™ XC injectable gel for use during pregnancy, in women who are breastfeeding, or in patients with very thin skin in the cheek area has not been studied
  • The safety for use in patients under 35 years or over 65 years has not been studied
  • The safety and effectiveness for treatment in areas other than the cheek area have not been established
  • The safety for use in patients with a history of excessive scarring or pigmentation disorders has not been studied and may result in additional scars or changes in pigmentation
  • The long-term safety of repeat treatments has not been established
  • Patients who experience skin injury near the site of injection may be at a higher risk for side effects
  • Tell your doctor if you are on therapy used to decrease the body’s immune response (immunosuppressive therapy). Use may result in an increased risk of infection
  • Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners; as with any injection, this may result in increased bruising or bleeding at the injection site
  • Minimize strenuous exercise and exposure to extensive sun or heat within the first 24 hours following treatment

What are possible side effects?

Side effects are moderate (uncomfortable) and generally last 2 to 4 weeks. The most common side effects include temporary reactions at the treatment site such as tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching.

To report a side effect, please call Allergan Product Surveillance at 1-877-345-5372.

For more information, please see the About Safety page at www.juvederm.com or call the Allergan Product Support line at 1-800-766-0171.

It is never too late, To be what you might have been.- George Eliot